Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 23, 2025, Oragenics (OGEN) has a market cap of $3.898 million USD. According to our data, Oragenics is ranked No.9100 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 23, 2025 | $3.90 M |
-16.34%
|
| Dec 31, 2024 | $4.66 M |
-93.43%
|
| Dec 29, 2023 | $70.89 M |
-14.70%
|
| Dec 30, 2022 | $83.11 M |
-75.56%
|
| Dec 31, 2021 | $0.34 B |
0.00%
|
| Dec 31, 2020 | $0.34 B |
-13.46%
|
| Dec 31, 2019 | $0.39 B |
-39.53%
|
| Dec 31, 2018 | $0.65 B |
-62.61%
|
| Dec 29, 2017 | $1.74 B |
-57.41%
|
| Dec 30, 2016 | $4.08 B |
-64.00%
|
| Dec 31, 2015 | $11.33 B |
68.54%
|
| Dec 31, 2014 | $6.72 B |
-68.33%
|
| Dec 31, 2013 | $21.23 B |
6.44%
|
| Dec 31, 2012 | $19.95 B |
161.39%
|
| Dec 30, 2011 | $7.63 B |
-66.33%
|
| Dec 31, 2010 | $22.67 B |
-50.00%
|
| Dec 31, 2009 | $45.33 B |
20.00%
|
| Dec 31, 2008 | $37.78 B |
-39.02%
|
| Dec 31, 2007 | $61.95 B |
-62.73%
|
| Dec 29, 2006 | $166.22 B |
155.81%
|
| Dec 30, 2005 | $64.98 B |
-88.83%
|
| Dec 31, 2004 | $581.76 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Vericel
VCEL
|
$2.89 B |
0.000 M
|
USA
|
 Mesoblast
MESO
|
$2.03 B |
0.000 M
|
Australia
|
 Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
 Capricor Therapeutics
CAPR
|
$0.68 B |
0.000 M
|
USA
|
 BrainStorm Cell Therapeutics
BCLI
|
$12.15 M |
0.000 M
|
USA
|
 Lineage Cell Therapeutics
LCTX
|
$0.15 B |
-0.000 M
|
USA
|
| Market Cap | = | OGEN Stock Price | * | OGEN Shares Outstanding |
| = | $0.28 | * | 13.71 M | |
| = | $3.90 M |